Firm record

ALTEOGEN

◇Private·South Korea·GICS Pharmaceuticals, Biotechnology and Life Sciences

This is a partial record assembled from open public datasets (WBA, Net Zero Tracker, SBTi, TPI, CDP). Reverberate's deeper extraction layer covers a curated cohort of firms — see the full directory for firms with verified financial + multi-year disclosure depth.

Partial profile

We haven't fully researched ALTEOGEN yet.

Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.

We’ll only use your email to notify you about this request.

Targets & commitments4

Source	Type	Scope	Base	Target year	Value	Status
sbti	—	—	—	—	—	—
sbti	—	—	—	—	—	—
sbti	near_term	Scope 1 + 2	2024	2035	63%	1.5°C
sbti	near_term	3	2024	2035	38%	—

Identifiers

isin	KR7196170005
sbti_id	40028104
Reverberate ID	740db497…